In a challenging market environment, Varex Imaging Corp (NASDAQ:VREX) stock has touched a 52-week low, dipping to $13.07. The company, known for its medical X-ray tubes and digital detectors, has faced a tumultuous year, with its stock price reflecting a significant downturn. Over the past year, Varex Imaging has seen its value decrease by 37%, a stark contrast to its previous performance. Investors are closely monitoring the company's strategic moves and market conditions, as the stock currently hovers at this low point, signaling caution and the potential for a critical reassessment of the company's financial health and future prospects.
In other recent news, Varex Imaging Corporation reported mixed second-quarter earnings for fiscal year 2024, with revenues of $206 million. The company observed a 15% year-over-year decrease in its Medical segment, but a 6% rise in its Industrial segment. Non-GAAP earnings per share were $0.16, and the company ended the quarter with a strong cash position of $190 million. Despite the adoption of its photon-counting technology, Varex adjusted its revenue expectations for the remainder of the fiscal year due to cautious purchasing behavior and market challenges in China, expecting flat revenue in the fourth quarter compared to the third.
In addition, Jefferies recently revised its outlook on Varex Imaging, lowering the price target to $17 from $18 while maintaining a Hold rating on the stock. The firm's discussions with Varex's senior management revealed that despite current challenging trends, the company anticipates an improvement in market conditions within the next one to two quarters. This expectation is based on the belief that issues such as customer destocking and regulatory challenges in China are nearing resolution.
These are the recent developments for Varex Imaging. The company's management remains focused on navigating the present challenges and capitalizing on potential market improvements. Jefferies' revised price target and Hold rating indicate a modest adjustment in the investment firm's expectations for Varex Imaging's performance, advising investors to maintain their current position in the stock without advocating for additional investment or divestment at this time.
InvestingPro Insights
In light of Varex Imaging Corp's (VREX) recent market performance, InvestingPro data reveals a market capitalization of $583.01 million, with a P/E ratio that stands at 17.82. Notably, the company's adjusted P/E ratio for the last twelve months as of Q2 2024 is more attractive at 11.23, indicating a lower price relative to near-term earnings growth. This is further complemented by a PEG ratio of 0.42, suggesting that the stock may be undervalued based on expected growth rates.
Despite a revenue decline of 2.72% over the last twelve months as of Q2 2024, Varex Imaging maintains a strong gross profit margin of 32.39%. Additionally, with a price-to-book ratio of just over 1, the company's stock is trading near tangible asset value. InvestingPro Tips highlight that Varex Imaging is expected to remain profitable this year and has a robust free cash flow yield, which could be compelling for value investors. Furthermore, the company's liquid assets exceed short-term obligations, providing financial stability.
For investors seeking further analysis and tips, InvestingPro offers additional insights, including the fact that analysts have revised their earnings estimates downwards for the upcoming period and that the stock is trading near its 52-week low, which could represent a potential entry point for long-term investors. There are 9 more InvestingPro Tips available, offering a comprehensive view of Varex Imaging's financial health and stock performance. These tips can be accessed through the InvestingPro platform for those looking to delve deeper into VREX's investment profile.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.